423 related articles for article (PubMed ID: 12614752)
21. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
Blinder KJ; Blumenkranz MS; Bressler NM; Bressler SB; Donato G; Lewis H; Lim JI; Menchini U; Miller JW; Mones JM; Potter MJ; Pournaras C; Reaves A; Rosenfeld P; Schachat AP; Schmidt-Erfurth U; Sickenberg M; Singerman LJ; Slakter JS; Strong HA; Virgili G; Williams GA
Ophthalmology; 2003 Apr; 110(4):667-73. PubMed ID: 12689884
[TBL] [Abstract][Full Text] [Related]
22. Influence of verteporfin photodynamic therapy on inflammation in human choroidal neovascular membranes secondary to age-related macular degeneration.
Tatar O; Adam A; Shinoda K; Yoeruek E; Szurman P; Bopp S; Eckardt C; Bartz-Schmidt KU; Grisanti S
Retina; 2007; 27(6):713-23. PubMed ID: 17621180
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy.
Ghazi NG; Jabbour NM; De La Cruz ZC; Green WR
Retina; 2001; 21(5):478-86. PubMed ID: 11642377
[TBL] [Abstract][Full Text] [Related]
24. Spotlight on verteporfin in subfoveal choroidal neovascularisation.
Keam SJ; Scott LJ; Curran MP
Drugs Aging; 2004; 21(3):203-9. PubMed ID: 14979737
[TBL] [Abstract][Full Text] [Related]
25. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
Verteporfin In Photodynamic Therapy Study Group
Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
[TBL] [Abstract][Full Text] [Related]
26. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.
Voelker M; Gelisken F; Ziemssen F; Wachtlin J; Grisanti S
Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1241-6. PubMed ID: 16010552
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study.
Rosenfeld PJ; Saperstein DA; Bressler NM; Reaves TA; Sickenberg M; Rosa RH; Sternberg P; Aaberg TM; Aaberg TM;
Ophthalmology; 2004 Sep; 111(9):1725-33. PubMed ID: 15350329
[TBL] [Abstract][Full Text] [Related]
28. Large submacular hemorrhages after verteporfin therapy.
Do DV; Bressler NM; Bressler SB
Am J Ophthalmol; 2004 Mar; 137(3):558-60. PubMed ID: 15013883
[TBL] [Abstract][Full Text] [Related]
29. Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults.
Rogers AH; Duker JS; Nichols N; Baker BJ
Ophthalmology; 2003 Jul; 110(7):1315-20. PubMed ID: 12867384
[TBL] [Abstract][Full Text] [Related]
30. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
Augustin AJ; Schmidt-Erfurth U
Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
[TBL] [Abstract][Full Text] [Related]
31. Time course and morphology of vascular effects associated with photodynamic therapy.
Schmidt-Erfurth U; Niemeyer M; Geitzenauer W; Michels S
Ophthalmology; 2005 Dec; 112(12):2061-9. PubMed ID: 16325705
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic therapy for juxtafoveal choroidal neovascularization in myopic eyes.
Cohen SY; Bulik A; Dubois L; Quentel G
Am J Ophthalmol; 2003 Aug; 136(2):371-4. PubMed ID: 12888071
[TBL] [Abstract][Full Text] [Related]
33. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
Azab M; Boyer DS; Bressler NM; Bressler SB; Cihelkova I; Hao Y; Immonen I; Lim JI; Menchini U; Naor J; Potter MJ; Reaves A; Rosenfeld PJ; Slakter JS; Soucek P; Strong HA; Wenkstern A; Su XY; Yang YC;
Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216
[TBL] [Abstract][Full Text] [Related]
34. Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
Japanese Age-Related Macular Degeneration Tial (JAT) Study Group
Am J Ophthalmol; 2003 Dec; 136(6):1049-61. PubMed ID: 14644215
[TBL] [Abstract][Full Text] [Related]
35. Photodynamic therapy for juxtafoveal choroidal neovascularization due to ocular histoplasmosis syndrome.
Shah GK; Blinder KJ; Hariprasad SM; Thomas MA; Ryan EH; Bakal J; Sharma S
Retina; 2005 Jan; 25(1):26-32. PubMed ID: 15655437
[TBL] [Abstract][Full Text] [Related]
36. Verteporfin photodynamic therapy induced apoptosis in choroidal neovascular membranes.
Petermeier K; Tatar O; Inhoffen W; Völker M; Lafaut BA; Henke-Fahle S; Gelisken F; Ziemssen F; Bopp S; Bartz-Schmidt KU; Grisanti S
Br J Ophthalmol; 2006 Aug; 90(8):1034-9. PubMed ID: 16613924
[TBL] [Abstract][Full Text] [Related]
37. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.
Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA; Tewari A
Retina; 2006; 26(9):988-93. PubMed ID: 17151484
[TBL] [Abstract][Full Text] [Related]
38. Photodynamic therapy with verteporfin in mallatia leventinese.
Dantas MA; Slakter JS; Negrao S; Fonseca RA; Kaga T; Yannuzzi LA
Ophthalmology; 2002 Feb; 109(2):296-301. PubMed ID: 11825812
[TBL] [Abstract][Full Text] [Related]
39. Sequence of early vascular events after photodynamic therapy.
Michels S; Schmidt-Erfurth U
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2147-54. PubMed ID: 12714655
[TBL] [Abstract][Full Text] [Related]
40. Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases.
Wachtlin J; Heimann H; Behme T; Foerster MH
Graefes Arch Clin Exp Ophthalmol; 2003 Nov; 241(11):899-906. PubMed ID: 14556077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
